Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
117 participants
OBSERVATIONAL
2006-12-01
2017-07-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. The range of cognitive deficits with emphasis on domains affected by vascular disease in patients with advanced CKD and those receiving hemodialysis.
2. The associations between severity of cognitive impairment and severity of kidney disease.
3. The prevalence of impaired IADLs and the level of health-related quality of life (HRQOL) in patients with advanced CKD and those requiring hemodialysis.
4. The relationship or association of cognitive impairment with IADL and HRQOL.
Secondary objective is to determine:
1\. The relationships among cerebral and carotid blood flow, carotid artery stiffness, and renal specific metabolic abnormalities with cognitive impairment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Telemonitoring to Improve Outcomes of Patients With Chronic Kidney Disease (CKD)
NCT01446029
Care Coordination/Home Telehealth to Safeguard Care in CKD
NCT03038126
Cognitive Impairment and Imaging Correlates in End Stage Renal Disease
NCT01883349
Impact of Early Renal Involvement on the Development of Severe In-hospital Renal Failure
NCT00806039
Chronic Kidney Disease (CKD) Guideline Adherence - A Quality Improvement Study
NCT00921687
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
No kidney disease
No interventions assigned to this group
PreHD kidney disease
Kidney disease stage 4 or below
No interventions assigned to this group
Hemodialysis
Kidney disease receiving hemodialysis
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male or female with an age of 18 years or older (no upper limit);
* Patients with stage III-IV CKD attending the renal primary care clinic or renal consult clinic;
* Fluent in English;
* Outpatient or stable nursing home patient
HD Subjects:
* Receiving HD for at least two weeks;
* Male or female with an age of 18 years or older (no upper limit);
* Fluent in English;
* Outpatient or stable nursing home patient
Control Subjects:
* Glomerular filtration rate of 60 cc/minute or greater;
* Male or female with an age of 18y or older (no upper limit);
* Fluent in English
* Outpatient
Exclusion Criteria
* Acute illness;
* Clinical history of stroke, dementia, or Parkinson's disease;
* Hb \<10;
* Liver function tests 2x upper limit of normal;
* Hemodialysis
HD Subjects:
* Acute illness;
* Clinical history of stroke, dementia, or Parkinson's disease;
* Hb \<10;
* Liver function tests 2x upper limit of normal;
* URR \<65% (measure of dialysis adequacy: will use 3-month average from chart)
Control Subjects:
* Acute illness;
* Clinical history of stroke, dementia, or Parkinson's disease;
* Hb \<10;
* Liver function tests 2x upper limit of normal;
* Stage 3-4 CKD;
* Hemodialysis
18 Years
89 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James B Post, MD
Role: PRINCIPAL_INVESTIGATOR
James J. Peters Veterans Affairs Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
James J. Peters VA Medical Center, Bronx, NY
The Bronx, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Post JB, Jegede AB, Morin K, Spungen AM, Langhoff E, Sano M. Cognitive profile of chronic kidney disease and hemodialysis patients without dementia. Nephron Clin Pract. 2010;116(3):c247-55. doi: 10.1159/000317206. Epub 2010 Jul 2.
Post JB, Morin KG, Handrakis JP, Rivera DR, Yen C, Sano M, Spungen AM. Cognition may be related to arterial pulsatility index in HD patients. Clin Nephrol. 2014 May;81(5):313-9. doi: 10.5414/cn107998.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B5050W-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.